Toggle Navigation
Follow @eaonc
Home
About Us
Organizational Overview
Executive Leadership
Governance
Our Members
Scientific Planning and Review
Trial Monitoring
Operations
Biostatistics and Data Management
Collaborations
Active Clinical Trials
Find a Participating Institution
Scientific Achievements
Constitution
Scientific Programs
Cancer Control and Outcomes Program
Therapeutic Studies Program
Biomarker Sciences Program
Research Support
Research Support Committees
Mentoring Program
Training and Education
Research Cores
Central Biorepository and Pathology Facility
Imaging Core Laboratory
Leukemia Translational Science Center
Thoracic Malignancies Integrated Translational Science Center
Resources
Active Clinical Trials: Resources
Group Meetings
Comis Translational Science Symposium
NCI-MATCH / EAY131 for Researchers
Publications
ECOG Performance Status
ECOG-ACRIN Sample Tracking System
CIRB
Medidata Rave®
TRIAD™
SOAPP
PrECOG
Related Websites
Document Library
Patients
Myths and Facts
External Resources and Links
Active Clinical Trials: Resources
News and Info
Advocacy Blog
Member Blog
Press Releases
Contact Us
Donations
Locations
Office of Communications
Find a Participating Institution
Principal Investigators
Follow @eaonc
Biomarker Steering Committee
Leadership
Co-Chair
Keith T. Flaherty, MD
Harvard University, the Dana-Farber/Harvard Cancer Center, and the Massachusetts General Hospital Cancer Center
Biography
Email
Co-Chair
Stanley R. Hamilton, MD
City of Hope
Biography
Email
Co-Chair
David A. Mankoff, MD, PhD
University of Pennsylvania and the Abramson Cancer Center
Biography
Email
Co-Chair
Anthony F. Shields MD, PhD
Wayne State University and the Barbara Ann Karmanos Cancer Institute
Biography
Email
28
Scientific Programs
Cancer Control and Outcomes Program
Therapeutic Studies Program
Biomarker Sciences Program
Biomarker Steering Committee
Developmental Therapeutics Committee
Imaging Committee
Laboratory Science and Pathology Committee
ECOG-ACRIN BY THE NUMBERS
Loading Quotes...